Legal Representation
Attorney
Sarah Anne Keefe
Application History
5 events| Date | Code | Type | Description |
|---|---|---|---|
| Jul 11, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jul 10, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
| Feb 6, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Feb 6, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Feb 6, 2025 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated diseases
Classification
International Classes
005
USPTO Documents
Loading USPTO documents...